WilmerHale Hires Life Sciences Partner From McDermott (2)

WilmerHale has hired corporate partner Sarah Hogan, who specializes in life sciences and digital health licensing transactions, from McDermott Will & Emery in Boston.

Hogan represents companies on complex transactions including the commercialization of pharmaceutical products, patent licensing, software and data transactions, supply and distribution agreements, and joint ventures. Her clients have included start-up companies, venture capital and private-equity backed companies, public companies, hospitals, and research institutions.

She represented Baxalta in a collaboration with Precision BioSciences to develop a cancer therapy, and Innate Pharma SA in its 2015 collaboration with AstraZeneca in the development of an immunotherapy drug.

Hogan said ...